Compare Logitech International SA (LOGI) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs TransMedics Group Inc — how do they compare? Logitech International SA trades at $103.79 (market cap $14.96B), while TransMedics Group Inc trades at $87.08 (market cap $3.10B). The key difference: Logitech International SA is far larger — about 4.8× TransMedics Group Inc's market cap, and Logitech International SA pays a 1.64% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| LOGI | TMDX | |
|---|---|---|
Market Cap | $14.96B | $3.10B |
Sector | Technology | Technology |
52-Week High | $126.69 | $150.42 |
52-Week Low | $85.84 | $61.99 |
Enterprise Value | $13.30B | $3.49B |
Dividend Yield | 1.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $103.28, down 1.52% on the day, with a bearish technical signal and mixed analyst sentiment. Recent Q1 2027 earnings beat expectations with EPS of $1.85 versus $1.26 expected, driven by tariff refunds and premium demand. However, a semiconductor supplier shutdown poses near-term supply chain risks. The stock shows strong profitability with a net margin of 16.28% and ROE of 35.29%, but valuation multiples like P/E of 19.03 and P/S of 3.1 suggest moderate pricing.
Outlook is cautious due to supply constraints overshadowing solid fundamentals. The consensus price target is $109.75, offering ~6% upside, but investor sentiment is divided with equal buy and sell ratings. Key risks include execution on supply chain mitigation and competitive pressures in the gaming and peripherals market. Near-term performance hinges on resolving supplier issues to meet robust demand.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
